This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on ISI (3)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Hematology/ Hematologic Malignancies  • Hematology, Other  • Immunologic Disorders  • Alert me on articles by topic

A Unique Manifestation of Transfusion-Associated Cutaneous Graft-vs-Host Disease

Shinobu Saijo, MD; Motoko Honda, MD; Youji Sasahara, MD; Tasuke Konno, MD; Hachiro Tagami, MD

Arch Dermatol. 2000;136:743-746.

Background  In 1978, the first case of columnar epidermal necrosis was reported in a 6-year-old boy. There were scaly, partially vesicular or crusty, erythematous lesions mainly involving the extremities that histopathologically showed peculiar features of focal, total epidermal necrosis accompanied by a lichenoid tissue reaction. He developed the skin eruption after receiving a blood transfusion from his mother when he showed debility induced by vaccination with an alternated live measles virus vaccine. The lesions rapidly regressed after sun exposure. To our knowledge, there has been no report of a similar case despite such unique features.

Observation  We encountered a similar case of columnar epidermal necrosis in a 15-year-old Japanese girl with chronic graft-vs-host disease; the lesions occurred 3 months after the transfusion of peripheral blood stem cells from her HLA antigen–matched brother. However, there was no exacerbation of liver dysfunction, diarrhea, or bone marrow aplasia. The peculiar cutaneous lesions responded well to topical phototherapy.

Conclusion  These 2 patients shared a similarity in their lesions and circumstances under which the blood transfusion was performed to a debilitated patient from a close family member. We believe that focal epidermal necrosis observed in patients with this condition represents a variant of blood transfusion–associated lichenoid graft-vs-host disease that occurs uniquely in a skin-targeted fashion.

From the Department of Dermatology, Tohoku University School of Medicine (Drs Saijo, Honda, and Tagami), and the Department of Pediatric Oncology, Institute of Development, Aging, and Cancer, Tohoku University (Drs Sasahara and Konno), Sendai, Japan.

RELATED ARTICLE

Archives of Dermatology Reader's Choice: Continuing Medical Education
Arch Dermatol. 2000;136(6):811-812.
FULL TEXT